| Income Statement | 2025-06-30 | |||
|---|---|---|---|---|
| Other expense, net | -307 | |||
| Loss from operations | -52,899 | |||
| Interest income | 3,269 | |||
| Net loss | -49,937 | |||
| Unrealized loss on marketable securities | -105 | |||
| Comprehensive loss | -50,042 | |||
| Net loss per share attributable to common stockholders, basic | -1.04 | |||
| Net loss per share attributable to common stockholders, diluted | -1.04 | |||
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic | 48,133,609 | |||
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted | 48,133,609 | |||
CARGO Therapeutics, Inc. (CRGX)
CARGO Therapeutics, Inc. (CRGX)